Document is current
Any future updates will be listed below
-
Authors
Tratnig-Frankl, Merle
Kuchernig, Lukas
Birner, Klaudia
Schürer-Waldheim, Simon
Eidenberger, Anna
Schrittwieser, Johannes
Gumpinger, Markus
Faustmann, Georg
Baratsits, Magdalena
Leingang, Oliver
Reiter, Gregor S.
Schmidt-Erfurth, Ursula
- License Information
-
More Information
Article History
Received: 9 October 2025
Accepted: 17 March 2026
First Online: 27 March 2026
Declarations
:
: O.L. is an employee of RetInSight GmbH (Vienna, Austria), which provided the GA Monitor software used for biomarker segmentation in this study. U.S.-E. and G.R. are or have been scientific advisors to RetInSight GmbH. The company had no role in data analysis, interpretation, or manuscript preparation. All other authors declare no competing interests.
: GR: Scientific consultancy for Apellis Pharmaceuticals, Boehringer, Espansione, Nordic Pharma, Roche and research funding by institution: RetInSight. SE: Scientific consultancy for Abbvie, Apellis Pharmaceuticals, Aviceda, Boehringer, Complement Therapeutics, Heidelberg Engineering, Janssen, Kodiak, Novartis, ONL, Roche, Topcon and research funding by institution: Apellis, Genentech, Heidelberg Engineering, Kodiak, Novartis, RetInSight, Roche.
